Everett Harris & Co’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$995K Buy
17,478
+362
+2% +$20.6K 0.01% 159
2025
Q1
$959K Buy
17,116
+13,114
+328% +$735K 0.01% 149
2024
Q4
$246K Sell
4,002
-1,230
-24% -$75.6K ﹤0.01% 265
2024
Q3
$350K Sell
5,232
-2,770
-35% -$185K ﹤0.01% 219
2024
Q2
$535K Sell
8,002
-6,336
-44% -$423K 0.01% 177
2024
Q1
$1.02M Sell
14,338
-490
-3% -$34.8K 0.01% 134
2023
Q4
$1.25M Buy
14,828
+517
+4% +$43.5K 0.02% 121
2023
Q3
$1.23M Buy
14,311
+385
+3% +$33.1K 0.02% 116
2023
Q2
$1.3M Buy
13,926
+106
+0.8% +$9.88K 0.02% 119
2023
Q1
$1.31M Buy
13,820
+15
+0.1% +$1.42K 0.02% 118
2022
Q4
$1.39M Buy
13,805
+45
+0.3% +$4.52K 0.02% 114
2022
Q3
$1.17M Buy
13,760
+120
+0.9% +$10.2K 0.02% 117
2022
Q2
$1.17M Buy
13,640
+215
+2% +$18.5K 0.02% 127
2022
Q1
$1.21M Sell
13,425
-305
-2% -$27.4K 0.02% 134
2021
Q4
$1.37M Sell
13,730
-950
-6% -$95K 0.02% 121
2021
Q3
$1.36M Buy
14,680
+1,100
+8% +$102K 0.02% 123
2021
Q2
$1.16M Buy
13,580
+1,695
+14% +$144K 0.02% 137
2021
Q1
$1.03M Buy
11,885
+970
+9% +$84K 0.02% 136
2020
Q4
$920K Buy
10,915
+765
+8% +$64.5K 0.02% 137
2020
Q3
$811K Buy
10,150
+2,220
+28% +$177K 0.02% 140
2020
Q2
$703K Buy
7,930
+85
+1% +$7.54K 0.02% 145
2020
Q1
$738K Buy
7,845
+1,521
+24% +$143K 0.02% 133
2019
Q4
$682K Sell
6,324
-2,811
-31% -$303K 0.02% 159
2019
Q3
$875K Hold
9,135
0.02% 136
2019
Q2
$874K Buy
9,135
+6,360
+229% +$608K 0.02% 140
2019
Q1
$245K Sell
2,775
-305
-10% -$26.9K 0.01% 220
2018
Q4
$256K Sell
3,080
-40
-1% -$3.33K 0.01% 206
2018
Q3
$294K Buy
3,120
+135
+5% +$12.7K 0.01% 211
2018
Q2
$329K Sell
2,985
-560
-16% -$61.7K 0.01% 203
2018
Q1
$350K Hold
3,545
0.01% 193
2017
Q4
$289K Buy
3,545
+225
+7% +$18.3K 0.01% 208
2017
Q3
$244K Buy
3,320
+425
+15% +$31.2K 0.01% 217
2017
Q2
$210K Buy
+2,895
New +$210K 0.01% 223